Falsified or Substandard? Assessing Price and Non-Price Signals of Drug Quality
Roger Bate, Gingner Jin and Aparna Mathur
,
4
(
24
)
Journal of Economics & Management Strategy
687-711
December
2015
Abstract
Pharmaceutical products can be of poor quality either because they contain zero correct active ingredient (referred to as “falsified”) or because they contain a non-zero but incorrect amount of the right active ingredient (referred to as “substandard”).
